The Ethics Problems Plaguing Trump’s Cabinet Have Sunk Plenty Of Prior Nominees – Huffington Post
In testimony before the Senate Health, Education, Labor & Pensions Committee, Price, Trump’s pick to run the Department of Health & Human Services, admitted that he purchased stock in a private placement for a biotechnology company after Rep. Chris Collins (R-N.Y.), a board member of the company, talked up the company to him. This immediately raised questions of whether Collins had shared non-public information with Price, which Price denied. Ethics experts agreed that if Price did receive information not available to the public, that would constitute insider trading.
Write a Reply or Comment:
You must be logged in to post a comment.